JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B1317 ML-323

Target: Deubiquitinating enzymes (DUBs)

Summary: USP1-UAF1 inhibitor
B1188 Lenalidomide hemihydrate

Summary: TNF-α secretion inhibitor

insoluble in H2O; insoluble in EtOH; ≥30.1 mg/mL
B2158 Desonide

Summary: nonfluorinated corticosteroid anti-inflammatory agent
B1387 (-)-Blebbistatin
10 Citation

Target: Myosin II ATPases

Summary: non-muscle myosin II inhibitor

insoluble in EtOH; insoluble in H2O; ≥14.62 mg/mL
B1548 Cyclizine 2HCl

Target: Histamine H1 Receptors

Summary: Histamine H1 receptor antagonist

Soluble in DMSO
B1376 Flutamide

Summary: Androgen receptor antagonists

insoluble in H2O; ≥12.5 mg/mL
B2196 Gliquidone

Summary: ATP-sensitive K+ channel antagonist

≥22.4 mg/mL
B2306 IWR-1-endo
1 Citation

Summary: Potent Wnt signaling inhibitor

insoluble in EtOH; insoluble in H2O; ≥20.45 mg/mL
B1543 Mubritinib (TAK 165)

Target: ErbB

Summary: Potent inhibitor of HER2/ErbB2; A mitochondrial electron transport chain complex I inhibitor

insoluble in H2O; ≥76.9 mg/mL
B2273 Procaine HCl

Summary: inhibitor of sodium channel, NMDA receptor and nAChR

≥17.07 mg/mL